INTRODUCTION
Cell apoptosis, which involves the biologic regulation of the numbers and vital activity of cells, is an important metabolic process in both normal cells and tumor cells. Delayed process of cell apoptosis will probably lead to a disturbance of metablism, and occurrence and development of neoplasms. Song et al[1] have proved the relationship between apoptosis delay and tumor development through inhibition of cell apoptosis induced by tumor promotor. Thus, induction of cell apoptosis could be a new strategic measure against tumor. In this paper, we studied whether arsenic oxide will induce apoptosis of gastric cancer cell lines (GCCL) to explore the use of such chemical agent against gastric cancer in clinic.
MATERIALS AND METHODS
Target cells
Human gastric cancer cell lines, MKN45 and SGC7901 (provided by Chinese Academy of Sciences) were used as target cells. Human leukemia cell line K562 and human peripheral blood lymphocytes (PBL) were used as controls. All of cells were cultured in RMPI 1640 medium (GIBICO-BRL), supplemented with 10% heat-inactivated fetal calf serum, 100 U/mL penicillin and 100 mg/mL streptomycin, in a humidified atmosphere of 95% air/5% CO2 at 37 °C. The numbers of four kinds of cells were maintained at 1 × 106/mL by daily adjusting cell concentration.
Product of arsenic trioxide (As2O3)
Ai-Lin No. 1 containing As2O3 was prepared by pharmacy of our hospital. Stock solution was made at the concentration of 1 mmol/L with phosphate-buffered saline (PBS) and diluted with RMPI 1640 to working concentration before use.
Cytocide test
MTT [3-(4,5-dimethythiazoyl-2-yl)2,5-diphenylte-trozoliumbromide] colori metric analysis was used to measure the cytocide rate of As2O3. Well grown cells were collected and were put into 96 well culture plate at 1 × 104/well. As2O3 was added to culture plate at the concentration of 5 μmol/well, while cells stuck on wall, 6 duplicate wells were set up in each sample in both experimental and control groups. Cells were cultrured for 24 h, 48 h and 72 h separately, MTT(5 mg/mL) was add ed at 10 μL/well. Acidulated isopropanol was finally added at 100 μL/well-after 2 h culture; values of OD570 were obtained on autocolorimeter. Cytocide rate was calculated by the following formula:
Cytocide rate (%) = [(Control OD - Experimental OD)/Control OD] × 100%
Apoptosis detection
Cell treatment MKN45 and SGC7901 cells of 106 were treated with As2O3 of the concentration of 5 μmol and 10 μmol, or with 5-Fu (0.5 g/L), or without any treatment as control. Cells were harvested after 24 h, 48 h and 72 h culture for apoptosis detection.
TDT label Consulting Gregory modified method[2]: PBS containing 1% formalin was added to cells at 4 °C. Thirty min later, it was washed twice with PBS, then reacted with 0.5 μg terminal deoxynucleotidyl transferase (TDT) and 0.5 μmol biotinylted dUTP at 37 °C for 30 min. Afterwards it was washed again with PBS, finally labelled by affinitin-fluorescin isothiocyanate (FITC) at room temperature for 30 min. DNA strand will be broken off during apoptosis, which can be labelled by dUTP and the positive observable fluorescences were seen under fluorescent microscope.
Flow cytometry (FCM) assays and fluorescent photographing The stimulating wave length of FCM (Becton Dickson FAC Scan)is 488 nm, FITC detection spectrum is between 80 and 630 nm. A total of 2000 cells were counted. Results were recorded and analyzed automatically.
Preparation of specimen for electronic microscopy MKN45 cells treated with As2O3 of concentration of 10 μmol for 72 h were washed with PBS and fetal calf serum; 25% glutaraldehyde was added to fix the cell specimens for 12 h. Then it was washed twice with 0.1 mol/L phosphoric buffer solution; the specimens were fixed with 1% osmi c acid, and were dehydrated step by step with alcohol and acetone; then covered up with Epon 812 epoxy vesin. Sections were made by ultramicrotome and dyed with uranium acetate and citric acid, and finally observed under transmission electronic microscope.
RESULTS
Cytocide rate of As2O3 on GCCL
Our results showed that As2O3 had higher cytotoxicity on GCCL than on K562 (P < 0.05). The effect of cytocide was observed at 24 h after reaction, and it increased with time (Table 1).
Table 1.
Group | MKN45 | 7901 | K562 | PBL |
24 h | 69.45 ± 11.12 | 68.27 ± 8.27 | 51.36 ± 10.25a | 30.31 ± 5.12b |
48 h | 71.40 ± 10.15 | 69.04 ± 11.31 | 57.11 ± 7.45a | 35.67 ± 4.37b |
72 h | 80.53 ± 10.18 | 82.74 ± 9.14 | 65.33 ± 8.24a | 39.74 ± 8.27b |
Comparison of cytocide rate between GCCL and controls by As2O3,
P < 0.05 (t > 2.2262),
P < 0.01 (t > 3.250)
GCCL apoptosis rate induced by As2O3
As shown in Table 2, apoptosis rates of 2 kinds of GCCL induced by 5-Fu were also obviously higher than natural cell apoptosis rate, of controls, which suggested that antitumor drug can kill tumor cells by inducing cell apoptosis. Nevertheless, a more significant cytocide effect of As2O3 on GCCL was demonstrate d in our study compared with that of 5-Fu. We found that apoptosis rate of GCCL induced by As2O3 is correlated with the concentration and reaction time of As2O3 (Table 3).
Table 2.
Group | Controls | 5-Fu | As2O3 1 | As2O3 2 |
24 h | 4.71 ± 0.36 | 18.04 ± 1.50 | 32.33 ± 3.75a | 60.02 ± 7.41b |
48 h | 14.90 ± 0.94 | 24.39 ± 3.45 | 90.59 ± 10.35b | 97.05 ± 8.24b |
72 h | 28.98 ± 3.12 | 41.47 ± 2.24 | 98.10 ± 13.24b | 98.75 ± 11.53b |
Comparison of apoptosis rate between As2O3 and 5-Fu group,
P < 0.05 (t > 2.2262),
P < 0.01 (t > 3.250).
Table 3.
Group | Controls | 5-Fu | As2O3 1 | As2O3 2 |
48 h | 7.44 ± 0.60 | 34.28 ± 4.15 | 51.33 ± 5.16a | 78.31 ± 9.14b |
72 h | 30.90 ± 2.54 | 56.32 ± 4.56 | 78.15 ± 6.78a | 89.28 ± 10.26b |
Comparison of apoptosis rate between As2O3 and 5-Fu group,
P < 0.05 (t > 2.2262),
P < 0.01 (t > 3.250)
The morphology of GCCL apoptosis under fluorescent microscope:
Under fluorescent microscope, the apoptosis cell can be seen after being terminally labelled (positive), but nonapoptotic cells were not labelled by fluorescin isothiocyanate (negative). The positive staining showed bright green fluorescence. Fluorescent spots appeared in early stage, and these fluorescent bodies gathered like a bunch of grapes in late stage. The cellular volume can be seen shrunken under the microscope.
The morphology of GCCL apoptosis under electronic microscope:
Under the transmission electronic microscope, typical morphologic changes of apoptotic GCCL (mainly cell nucleus) took place after treatment of As2O3. These changes included cell nucleus fixation and shrinkage of GCCL, chromatin condensation, and fragmentation of apoptotic bodies. These changes coexisted.
DISCUSSION
Some researchers have proposed that the uncontrolled growth of neoplasms would b e due to the loss of the nature of autoapoptosis rather than over proliferation. Previous studies have proved that there existed autoapoptosis blockage in tumor cells. Lauwers et al[3] examined bcl-2 gene in 46 cases of gastric adenocarcinoma by immunochemical method, revealling 75% positivity. Of bcl-2 gene in tumor tissues, which indicated that apoptosis was blocked in gastric cancer. Bcl-2 has been considered as one of survival genes which plays an important role in the specific-inhibition of tumor cell apoptosis[4]. Based on these findings, a new proposal of inducing apoptosis to inhibit tumor growth was introduced[5]. Many factors such as high temperature, cytokine, radiations and all kinds of anti-tumor chemotherapy drugs have a certain effect on inducing tumor cells apoptosis. But some of these are not satisfactory. Our aim is to find a specific-agent which can induce apoptosis of tumor cells. Vollmers et al[6] reported the suppressive effects of monoclonal antibody (SC-1) on both in vitro proliferation of gastric cancer cell line and growth of a tumor inoculated on nude mice. The inhibition of proliferation of tumor cells was produced through the induction of autoapoptosis, which has been proved by the observation of ultrastructure.
Arsenic is a major composition of traditional Chinese medicine, white arsenic. White arsenic has been considered as a carcinogen. It can inactivate some important enzymes in cells, change the metabolic process and induce chromosome aberration[7]. Zhang et al[8] reported a satisfactory result by using As2O3 for the treatment of early acute promyelocytic leukemia (APL). Complete remission was 73.3% in patients after the first therapeutic course, and 52.83% in recurrent patients. The longest remission period of APL patient was over 10 years. No obvious toxic reactions were found when As2O3 was given by iv drip, which is appropriate. Similar result has also been obtained by researchers at Shanghai Institute of Hematology of Shanghai Ruijin Hospital[9,10]. Recently, Zhang et al[11] demonstrated that Arsenic Oxide can inhibit growth of lymphosarcoma cells and induce apoptosis to these cells.
Based on the above studies, we applied As2O3 for the treatment of GI solid tumor. The results from in vitro study are impressive. Proliferation of MKN45 and SGC7901 was inhibited by As2O3 through apoptosis induction. Results also showed that As2O3 has a stronger effect of apoptosis induction than 5-Fu. Induction of apoptosis was enhanced with increase of concentration and time of As2O3. The question is what the optimal dosage is for clinical use so as to produce maximal effect with no toxicity. Further comprehensive researches are needed to clarify the significance of As2O3 for the treatment of GI solid tumors.
Footnotes
Dr. Qin-Long Gu, graduated from Bengbu Medical College in 1977, acquired MD & PhD degree in surgery from Shanghai Second Medical University in 1994, majoring in research in the field of tumor biological therapy and having 40 papers published.
Edited by Zhu LH
proofread by Sun SM
References
- 1.Song Q, Baxter GD, Kovacs EM, Findik D, Lavin MF. Inhibition of apoptosis in human tumour cells by okadaic acid. J Cell Physiol. 1992;153:550–556. doi: 10.1002/jcp.1041530316. [DOI] [PubMed] [Google Scholar]
- 2.Li NL, Shen BH, Zheng ZX, Zhou GY. Detection of DNA strand breaks in drug induced apoptosis of HL-60 and U973 cells by in situ terminal deoxynucleotidyl transferase. Zhongliu. 1996;16:391–393. [Google Scholar]
- 3.Lauwers GY, Scott GV, Karpeh MS. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer. 1995;75:2209–2213. doi: 10.1002/1097-0142(19950501)75:9<2209::aid-cncr2820750904>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
- 4.Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990;348:334–336. doi: 10.1038/348334a0. [DOI] [PubMed] [Google Scholar]
- 5.Sachs L, Lotem J. Control of programmed cell death in normal and leukemic cells: new implications for therapy. Blood. 1993;82:15–21. [PubMed] [Google Scholar]
- 6.Vollmers HP, Dämmrich J, Ribbert H, Wozniak E, Müller-Hermelink HK. Apoptosis of stomach carcinoma cells induced by a human monoclonal antibody. Cancer. 1995;76:550–558. doi: 10.1002/1097-0142(19950815)76:4<550::aid-cncr2820760403>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
- 7.Dong JT, Luo XM. Effects of arsenic on DNA damage and repair in human fetal lung fibroblasts. Mutat Res. 1994;315:11–15. doi: 10.1016/0921-8777(94)90022-1. [DOI] [PubMed] [Google Scholar]
- 8.Zhang P, Wang SY, Hu LH, Shi FD, Qiu FQ, Hong LJ, Han XY, Yang HF, Song YZ, Liu YP, et al. Treatment of acute promyelocytic leukemia with intravenous arsenic trioxide. Zhonghua Xueyexue Zazhi. 1996;17:58–60. [Google Scholar]
- 9.Chen GQ, Zhu J, Shi XG, Ni JH, Zhong HJ, Si GY, Jin XL, Tang W, Li XS, Xong SM, et al. In vitro studies on cellular and molecular mechanisms of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia: As2O3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood. 1996;88:1052–1061. [PubMed] [Google Scholar]
- 10.Sun YP, Chen GQ, Cai X, Huang Y, Sheng SY, Jia PM, Sheng YL, Yu Y, Chen SJ, Wang ZY, et al. Phenylarsine oxide induces apoptosis in acute promyelocytic leukemia cell line NB4. Aizheng. 1999;18:1–4. [Google Scholar]
- 11.Zhang W, Ohnishi K, Shigeno K, Fujisawa S, Naito K, Nakamura S, Takeshita K, Takeshita A, Ohno R. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia. 1998;12:1383–1391. doi: 10.1038/sj.leu.2401112. [DOI] [PubMed] [Google Scholar]